Screener
BridgeBio Pharma BBIO Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $680.04M-9.5% | $882.02M+62.5% | $170.49M-75.0% | $645.1M+58.2% | $751.1M+84.1% | ||
| $42.25M+432% | $60.3M— | $17.36M— | $2.99M— | $7.94M-80.1% | ||
| $254.48M+231% | $205.23M+78.0% | $139.44M+2,853% | $116.52M+64,121% | $76.87M+133% | ||
| $52.84M+189% | $32.98M+734% | $26.75M— | $24.53M— | $18.28M— | ||
| $1.09B+19.8% | $1.24B+78.6% | $797.75M+10.7% | $839.38M+88.8% | $912.28M+48.0% | ||
| $5.23M-14.4% | $4.94M-26.2% | $5.37M-23.5% | $5.83M-33.0% | $6.11M-37.9% | ||
| $26.64M-9.7% | $27.36M-1.6% | $28.08M+17.3% | $28.8M+17.4% | $29.51M+17.5% | ||
| $1.22B+12.7% | $1.37B+55.5% | $936.03M+1.8% | $998.25M+50.1% | $1.08B+36.0% | ||
| $27.2M+4.1% | $29.06M+5.6% | $36.23M+277% | $18.7M+40.0% | $26.13M+44.2% | ||
| $5.55M-62.2% | $6.12M-65.1% | $7.19M-50.8% | $9.09M-51.2% | $14.67M-13.5% | ||
| $588.5M— | $588.5M— | —— | $40.63M— | —— | ||
| $890.65M+406% | $816.37M+437% | $287.97M+86.5% | $216.6M+55.6% | $175.85M+30.9% | ||
| $2.65B— | $2.65B— | —— | $2.01B+360% | $0-100% | ||
| $3.72B+30.2% | $3.64B+44.4% | $3.01B+26.7% | $2.92B+55.1% | $2.86B+52.3% | ||
| 500M+252,425% | 500M+253,707% | 500M+255,002% | 500M+256,310% | 198K+2.1% | ||
| -$4.14B-20.1% | -$3.99B-22.1% | -$3.82B-23.4% | -$3.63B-28.2% | -$3.45B-29.1% | ||
| -$2.52B-40.7% | -$2.28B-38.2% | -$2.09B-42.1% | -$1.93B-57.2% | -$1.79B-63.6% | ||
| $1.22B+12.7% | $1.37B+55.5% | $936.03M+1.8% | $998.25M+50.1% | $1.08B+36.0% |
FAQ
- What are BridgeBio Pharma's total assets?
- BridgeBio Pharma (BBIO) holds $1.2B in total assets, up 12.7% year over year.
- How much debt does BridgeBio Pharma have?
- BridgeBio Pharma carries $3.3B in total debt against -$2.5B of shareholders' equity, a debt-to-equity ratio of 1.97.
- How much cash does BridgeBio Pharma have?
- BridgeBio Pharma holds $680.0M in cash and equivalents.
- Can BridgeBio Pharma cover its short-term obligations?
- Its current ratio is 1.23 — current assets exceed current liabilities.
- Where does BridgeBio Pharma's balance sheet data come from?
- Every line is extracted from BridgeBio Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
